Capital Research Global Investors’s Protolabs PRLB Stock Holding History

Capital Research Global Investors’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-282,000	Closed	-$22.6M	–	442
2017 Q3	$22.6M	Sell	282,000 -184,700	-40%	-$13.4M	0.01%	371
2017 Q2	$31.4M	Hold	466,700	–	–	0.01%	364
2017 Q1	$23.8M	Hold	466,700	–	–	0.01%	378
2016 Q4	$24M	Hold	466,700	–	–	0.01%	380
2016 Q3	$28M	Buy	466,700 +175,700	+60%	+$10.1M	0.01%	360
2016 Q2	$16.8M	Buy	+291,000	New	+$19.4M	0.01%	374

Other funds holding PRLB

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors's PRLB Position: Q4 2017 in Review

Capital Research Global Investors sold out of Protolabs (PRLB) in Q4 2017, closing a stake of 282,000 shares — an estimated $22.6M sold.

Capital Research Global Investors first reported a position in PRLB in Q2 2016 and held it in 6 quarters. The position peaked at $31.4M in Q2 2017. 230 funds tracked by Wall St. Rank hold PRLB as of Q4 2017.

Capital Research Global Investors reported no remaining Protolabs position as of Q4 2017 after selling out during the quarter.
Capital Research Global Investors sold 282,000 Protolabs shares in Q4 2017, an estimated $22.6M.
Capital Research Global Investors first reported a position in Protolabs in Q2 2016 and held it in 6 quarters.
Capital Research Global Investors's Protolabs position peaked at $31.4M in Q2 2017.
230 funds tracked by Wall St. Rank held Protolabs as of Q4 2017.

Based on Capital Research Global Investors's 13F filing for Q4 2017, filed 14 Feb 2018.